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Prospects for Clinical Research!
G. Donald Whedon, MD'

the year by which a considerable number of Institutes had
been founded and extramural programs had begun,
showed slow early beginnings and then a rapid growth
during the late 1950s and early 1960s. NIH support of
research increased steadily until the final years of the
Johnson Administration; then there was level funding over
the next six years and even an impoundment of funds in
1973; then "escape" during the Ford Administration. It
seems particularly appropriate for me to mention here one
ofthe very beneficial influences of the Ford Administration.
The "escape" varied from Institute to Institute but was
greatest for the National Cancer Institute (NCI) and the
National Heart, Lung, and Blood Institute (NHLBI), particularly from 1973-76. The budgetof the National Institute of
Arthritis, Metabolism, and Digestive Diseases (NIAMDD)
began to grow again during 1976-79, due mainly to phenomenal public and Congressional interest in diabetes.
Increased funding in recent years, of course, has meant
recovery, but a better physical sign for diagnosis of the state
of health of medical research has been the increase in
numbers of research grant app/ications, particularly during
the past two years, an indication of the vitality of interest in
research among investigators in universities and medical
centers.

0 ne of the principal reasons I have been invited to speak
here at Henry Ford Hospital is my very long friendship with
Richmond Smith. Rich and I go back to the 1940s when we
were research fellows (along with George Hamwi, Bill
Thomas, and Anne Carter) in Ephraim Shorr's Endocrinology Division of the New York Hospital-Cornell Medical
Center. The quality and effectiveness of Dr. Smith's hard
work in endocrinology and in internal medicine have been
well known over the years far beyond Detroit. Through all
the years that he has been here and I have been in
Bethesda, the close friendship of our early fellowship days
has persisted. There is something very special about early
friends; these are not only the longest of friendships, but
also the closest and best.
1 hope it will interest staff members of one of the greatest
clinical care establishments in the world to hear from us in
the National Institutes of Health (NIH), the institution
which supports with federal funds two thirds of medical
research in the U.S., some perspectives on support of
medical research and education. The association of medical research, education, and clinical care is probably far
closerthan any of us realize, but the quality of clinical care,
and probably its quanitity, are inevitably dependent upon
the quality and quantity of the development of new biomedical knowledge, the training of young physicians, and
the continual updating oftheir skills. From all that I have
seen and heard, particularly over the past few years, Henry
Ford Hospital fully understands and lives by the close
interrelationship of these three cardinal elements of
medicine.

Despite this reasonably healthy state at present, as indicated by funding and numbers of applications, leaders of
medical societies have recently expressed considerable
concern for the future of research and particularly of clinical research. The pertinent NIH data show that although
the actual number of M D investigators has held level over
the past half dozen years, the proportion of MDs among
principal investigators on research grants has declined, due
to the considerable increase in the number of PhDs as
principal investigators. We feel some reassurance from the
fact that MDs are scoring as well as PhDs in reviews oftheir
grant proposals and in the proportion of awards to the
number of appl ications. The data reviewed, however, show
disturbing portents for the future of training grants and
fellowships. Since 1974, the number of MDs receiving
research fellowships has steadily dropped. My concern for
the future of clinical research is increased by the knowledge that this drop in M D fellowships and traineeships is

In addressing the question, "What is the future of support
for medical research and education?" we recently examined all the NIH data we could on research grants and
training. The history of research grant funding from 1950,
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The resources of government support, however, can do
only so much. There must be an intrinsic or endogenous reawakening of interest in research, starting at the medical
student level in the medical schools. Equally important, the
great hospitals have an important role to play. Not only do
they provide the best care for patients but, like Henry Ford
Hospital, they are the major educational institutions for
postgraduate clinical training and experience, which takes
place through the residency and young physician levels.
Henry Ford Hospital is so renowned for quality of care that
its contributions to the development o f a "better product"
for the consumer patient are not fully appreciated, especially locally. For many, many years at a low and quiet
level, the Edsel Ford Institute for Medical Research put out
very sound research by men well known in their respective
fields. For many years, the clinicians, superbly trained,
were providing advances in clinical knowledge by their
astute observational powers, which were then communicated to the medical community at large through many
publications in many journals.

not due to a decrease in training funds, since fully one
fourth of the available training and fellowship slots have
not been filled.
There are probably several reasons for declining interest in
research on the part of medical students and residents.
1) Predominant interest in delivery of medical care.
2) An accompanying belief that society is more approving of the good physician than of the professor/
investigator.
3) Uncertainty as to the continuity or long-term stability
of support for research from the largest source of
support, the federal government (which I believe is
an exaggerated and unsound reason).
4) Revision in medical school curricula so that exposure
to laboratory techniques has been limited.
5) Recent changes in specialty board requirements and
increased interest in sub-specialty certification. After
graduation a longer time is spent in clinical diagnostic and care experience, and the opportunity to enter
research is long delayed. Growing economic pressures to go into practice are extremely difficult to
resist.
6) Economic pressure per se.

But now. Ford Hospital has just entered a new and potentially very great phase. Through the support of the Ford
Foundation, with the building of the Benson Ford Education
and Research Center, and the commitment o f t h e administration, all led by Richmond Smith, you are now putting
into action a superb demonstration ofthe interdependence
and inseparability of new knowledge produced by research, of medical education and clinical training, and of
quality care of patients. In this remarkable new setting, the
medical staff has the chance to lend a forceful hand to the
renaissance of c l i n i c a l investigation we surely need
nationally.

The NIH has already begun to respond to this situation in
several ways, particularly in the form of new or unusual
means of support for those interested in research careers.
These include so-called Young Investigator awards and, in
NIAMDD, a Clinical Investigator award program for individuals with four to seven years' postdoctoral experience.
In the field of diabetes we have just initiated a Special
Emphasis Research Career Award (SERCA) and a New
Investigator Research Award. Depending on our experience in diabetes, we probably could extend these two new
research exposure and "training" activities to other program areas.

I urge the medical staff here to have a stronger feeling of
their role, oftheir special opportunity, and oftheir responsibility, to do more in clinical research. Furthermore, renew
your efforts to infuse residents and affiliated medical students with a spirit of enjoyment, even excitement, in
observing, in measuring, in planning clinical experiments,
and in finding new facts and correlations that may give
clues to practical, positive influences on disease, the treatment of which is so much in the minds of medical students
and residents today.

Among other actions which the NIH will be taking, as of
J u l y l , 1980, is an increase in stipend levels for fellowships
and traineeships. Now being issued are announcements of
a revival of the "short-term training" program which will
take advantage of a revision the Congress made in the
National Research Service Act in fall of 1978. The revision
in this Act, which authorizes legislation for training, exempts from payback training periods of from two weeks
up to three months. "Non-payback training" of up to three
months should provide an opportunity to begin to instill
research principles into receptive students and might weigh
positively in the balance of a career choice. The requirement for "specialized intensive training courses," we
think, can be satisfied by having groups of trainees from a
number of training programs in the same school attend a
systematized series of seminars on research methodology,
technology, biostatistics, etc.

This brief message, accenting the undergirding importance
of research to clinical care, is not new to you, except
perhaps as a call for help in bringing about a recovery of
clinical investigation. You have heard this message from
Richmond Smith over all the years of his service to this
renowned institution. I simply urge you to hear him again,
or hear him still, and to continue the fine performance you
have made over the years under his leadership.
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